Design of novel pyrimidine based remdesivir analogues with dual target specificity for SARS CoV-2: A computational approach
- PMID: 37148943
- PMCID: PMC10158044
- DOI: 10.1016/j.ijbiomac.2023.124443
Design of novel pyrimidine based remdesivir analogues with dual target specificity for SARS CoV-2: A computational approach
Abstract
As the world undergone unpreceded time of tragedy with the corona virus, many researchers have raised to showcase their scientific contributions in terms of novel configured anti-viral drugs until now. Herein, we designed pyrimidine based nucleotides and assessed for the binding capability with SARS-CoV-2 viral replication targets of nsp12 RNA-dependent RNA polymerase and Mpro main protease. Molecular docking studies showed all the designed compounds to possess good binding affinity, with a few compounds which outperforms the control drug remdesivir GS-5743 and its active form GS-441524. Further molecular dynamics simulation studies confirmed their stability and preservation of the non-covalent interactions. Based on the present findings Ligand2-BzV_0Tyr, ligand3-BzV_0Ura, and ligand5-EeV_0Tyr showed good binding affinity with Mpro, whereas, ligand1-BzV_0Cys and Ligand2-BzV_0Tyr showed good binding affinity with RdRp, thus could act as potential lead compounds against SARS-CoV-2, which needs further validation studies. In particular, Ligand2-BzV_0Tyr could be more beneficial candidate with the dual target specificity for Mpro and RdRp.
Keywords: COVID-19; Corona virus; Covalent docking; Main protease; Molecular dynamics simulations; Molecular modelling; Pyrimidine based remdesivir analogues; RNA-dependent DNA polymerase; SARS CoV-2.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Jebasingh Bhagavathsingh reports were provided by Karunya Institute of Technology and Sciences. Jebasingh Bhagavathsingh reports a relationship with Karunya Institute of Technology and Sciences that includes: employment.
Figures










Similar articles
-
Computational Analysis Reveals Monomethylated Triazolopyrimidine as a Novel Inhibitor of SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp).Molecules. 2022 Jan 26;27(3):801. doi: 10.3390/molecules27030801. Molecules. 2022. PMID: 35164069 Free PMC article.
-
Identification of natural inhibitors against prime targets of SARS-CoV-2 using molecular docking, molecular dynamics simulation and MM-PBSA approaches.J Biomol Struct Dyn. 2022 Apr;40(7):3296-3311. doi: 10.1080/07391102.2020.1846624. Epub 2020 Nov 13. J Biomol Struct Dyn. 2022. PMID: 33183178 Free PMC article.
-
Combination of QSAR, molecular docking, molecular dynamic simulation and MM-PBSA: analogues of lopinavir and favipiravir as potential drug candidates against COVID-19.J Biomol Struct Dyn. 2022 May;40(8):3711-3730. doi: 10.1080/07391102.2020.1850355. Epub 2020 Nov 30. J Biomol Struct Dyn. 2022. PMID: 33251975 Free PMC article.
-
State-of-the-Art Molecular Dynamics Simulation Studies of RNA-Dependent RNA Polymerase of SARS-CoV-2.Int J Mol Sci. 2022 Sep 8;23(18):10358. doi: 10.3390/ijms231810358. Int J Mol Sci. 2022. PMID: 36142270 Free PMC article. Review.
-
The Functional Implications of Broad Spectrum Bioactive Compounds Targeting RNA-Dependent RNA Polymerase (RdRp) in the Context of the COVID-19 Pandemic.Viruses. 2023 Nov 25;15(12):2316. doi: 10.3390/v15122316. Viruses. 2023. PMID: 38140557 Free PMC article. Review.
Cited by
-
Synthesis of Ethyl Pyrimidine-Quinolincarboxylates Selected from Virtual Screening as Enhanced Lactate Dehydrogenase (LDH) Inhibitors.Int J Mol Sci. 2024 Sep 9;25(17):9744. doi: 10.3390/ijms25179744. Int J Mol Sci. 2024. PMID: 39273691 Free PMC article.
References
-
- Agostini Maria L., Andres Erica L., Sims Amy C., Graham Rachel L., Sheahan Timothy P., Xiaotao Lu., Smith Everett Clinton, Case James Brett, Feng Joy Y., Jordan Robert, Ray Adrian S., Cihlar Tomas, Siegel Dustin, Mackman Richard L., Clarke Michael O., Baric Ralph S., Mark R. Denisona. MBio. 2018;9 e00221-18. - PMC - PubMed
-
- World Health Organization; 15th November 2022. Corona disease (COVID-19) situation reports; pp. 1–11.https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio... on.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous